Newbury Pharmaceuticals Valuation Multiples

Newbury Pharmaceuticals Overview

About Newbury Pharmaceuticals

Newbury Pharmaceuticals AB is a hybrid pharmaceutical company for specialty prescription drugs, innovation and brands with focus on the Scandinavian markets.

Founded

N/A

HQ

Employees

5

Website

newburypharma.com

Sectors

BiopharmaceuticalsBioTech

Financials (FY)

Revenue: $3M

EBITDA: ($2M)

EV

$3M

Valuation Multiples

Multiples.vc

Start free trial

Newbury Pharmaceuticals Financials

Newbury Pharmaceuticals reported last fiscal year revenue of $3M and negative EBITDA of ($2M).

In the same fiscal year, Newbury Pharmaceuticals generated $1M in gross profit, ($2M) in EBITDA losses, and had net loss of ($3M).

Newbury Pharmaceuticals P&L

In the most recent fiscal year, Newbury Pharmaceuticals reported revenue of $3M and EBITDA of ($2M).

Newbury Pharmaceuticals expects next 12-month revenue of XXX and NTM EBITDA of XXX

Newbury Pharmaceuticals Stock Performance

Newbury Pharmaceuticals has current market cap of $4M, and enterprise value of $3M.

Newbury Pharmaceuticals' stock price is $0.14.

Newbury Pharmaceuticals Valuation Multiples

Newbury Pharmaceuticals trades at 0.9x EV/Revenue multiple, and (1.8x) EV/EBITDA.

Newbury Pharmaceuticals Financial Valuation Multiples

As of April 19, 2026, Newbury Pharmaceuticals has market cap of $4M and EV of $3M.

Equity research analysts estimate Newbury Pharmaceuticals' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Newbury Pharmaceuticals has a P/E ratio of (1.7x).

Newbury Pharmaceuticals Margins & Growth Rates

Newbury Pharmaceuticals' revenue in the last fiscal year declined by (10%).

Newbury Pharmaceuticals' revenue per employee in the last FY averaged $0.7M, while opex per employee averaged $0.7M for the same period.

Newbury Pharmaceuticals Public Comps

See public comps and valuation multiples for other Biopharmaceuticals comps.

Newbury Pharmaceuticals M&A Activity

Newbury Pharmaceuticals acquired XXX companies to date.

Last acquisition by Newbury Pharmaceuticals was on XXXXXXXX, XXXXX. Newbury Pharmaceuticals acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Newbury Pharmaceuticals Investment Activity

Newbury Pharmaceuticals invested in XXX companies to date.

Newbury Pharmaceuticals made its latest investment on XXXXXXXX, XXXXX. Newbury Pharmaceuticals invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).